Table 1.
Baselines of patients with hepatocellular carcinoma.
HCC | |
---|---|
Sex (m/f) | 24/4 |
Age (year) | 59 (40–78) |
ALT (U/L) | 40.2 ± 39.7 |
HBV DNA (Log10IU/ml) | 3.46 ± 2.28 |
TBil (mmol/L) | 18.9 ± 16.9 |
ALB (g/L) | 41.5 ± 4.3 |
AFP (ng/ml) | 3,517.9 ± 6,254.7 |
Baselines of patients with hepatocellular carcinoma.
HCC | |
---|---|
Sex (m/f) | 24/4 |
Age (year) | 59 (40–78) |
ALT (U/L) | 40.2 ± 39.7 |
HBV DNA (Log10IU/ml) | 3.46 ± 2.28 |
TBil (mmol/L) | 18.9 ± 16.9 |
ALB (g/L) | 41.5 ± 4.3 |
AFP (ng/ml) | 3,517.9 ± 6,254.7 |